Evidence map›Paper›PMID 25484581›Full record

ArticleInternational journal of nanomedicine2014

Effect of silk fibroin nanofibers containing silver sulfadiazine on wound healing.

Lim Jeong, Min Hee Kim, Ju-Young Jung, Byung Moo Min, Won Ho Park

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Silk Fibroin as a Functional Biomaterial for Tissue Engineering.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lim JeongDepartment of Advanced Organic Materials and Textile System Engineering, Chungnam National University, Daejeon, Seoul, South Korea.
Min Hee KimDepartment of Advanced Organic Materials and Textile System Engineering, Chungnam National University, Daejeon, Seoul, South Korea.
Ju-Young JungCollege of Veterinary Medicine, Chungnam National University, Daejeon, Seoul, South Korea.
Byung Moo MinDepartment of Oral Biochemistry, School of Dentistry, Seoul National University, Seoul, South Korea.
Won Ho ParkDepartment of Advanced Organic Materials and Textile System Engineering, Chungnam National University, Daejeon, Seoul, South Korea.
Seoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne of the promising applications of silk fibroin (SF) in biomedical engineering is its use as a scaffolding material for skin regeneration. The purpose of this study was to determine the wound healing effect of SF nanofibrous matrices containing silver sulfadiazine (SSD) wound dressings.

methodsAn SF nanofibrous matrix containing SSD was prepared by electrospinning. The cell attachment and spreading of normal human epidermal keratinocytes (NHEK) and normal human epidermal fibroblasts (NHEF) to SF nanofibers containing three different concentrations of SSD contents (0.1, 0.5, and 1.0 wt%) were determined. In addition, a rat wound model was used in this study to determine the wound healing effect of SF nanofibers containing SSD compared with that of Acticoat™, a commercially available wound dressing.

resultsThe number of NHEK and NHEF attached to SF nanofibers containing SSD decreased when the concentration of SSD increased. The number of attached NHEF cells was lower than that of attached NHEK cells. The SF matrix with 1.0 wt% SSD produced faster wound healing than Acticoat, although 1.0 wt% SSD inhibited the attachment of epidermal cells to SF nanofibers in vitro.

conclusionThe cytotoxic effects of SF nanofibers with SSD should be considered in the development of silver-release dressings for wound healing through its antimicrobial activity. It is challenging to design wound dressings that maximize antimicrobial activity and minimize cellular toxicity.

Indexed as

AnimalsCell AdhesionCells, CulturedFibroblastsFibroinsHumansKeratinocytesMaleNanofibersRatsRats, Sprague-DawleySilver SulfadiazineSkinWound HealingFibroinsSilver Sulfadiazinenanofibrous matrixsilk fibroinsilver sulfadiazinewound healing

Identifiers

PMID25484581
PMCPMC4238896
OpenAlexW2088266228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.